RxSource

RxSource is a global leader in clinical trial supply services, dedicated to enhancing patient outcomes by providing comprehensive solutions to the pharmaceutical and biotechnology industries.

Established in 2005, the company has expanded its operations across North America and Europe, with facilities in Canada, the United States, and Ireland.

Core Services

• Sourcing: RxSource specializes in the ethical sourcing of clinical trial materials, including comparator drugs, co-medications, rescue medications, and ancillary products. This ensures that clinical trials have access to necessary drugs and supplies, regardless of their complexity or location.
• Packaging & Labelling: The company offers secondary packaging and labelling services tailored to clinical trials, employing demand-led, traditional, or hybrid models to minimize waste while maintaining patient access. This approach ensures compliance with regulatory standards.
• Storage & Distribution: RxSource provides global storage and distribution services for clinical trial materials, including temperature-sensitive storage and lifecycle management. With facilities in North America and the EU, as well as approved depots in Latin America, Eastern Europe, Africa, and Asia, the company supports clinical trials worldwide.

Technological Advancements

To enhance its service offerings, RxSource has invested in the PRISYM 360 clinical labelling platform. This cloud-based solution enables the company to design and create labels in-house, optimizing label management processes and reducing traditional complexity and time involved in clinical labelling.

Global Presence

RxSource operates from several key locations which provide flexible, controlled, and capacity-driven solutions tailored to clinical trial needs. These ensure safe and efficient delivery of clinical trial materials worldwide.

• Collingswood, NJ, USA
• Richmond Hill, Ontario, Canada
• Dublin, Ireland, Europe

Commitment to Patients

With a strong commitment to improving the lives of patients, RxSource continues to expand its global footprint.

The company aims to positively impact the lives of 10 million patients over the next decade through its clinical trial supply services.